APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 41 filers reported holding APREA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $26,288 | -2.6% | 81,664 | +100.0% | 0.00% | – |
Q3 2022 | $27,000 | -10.0% | 40,832 | 0.0% | 0.00% | – |
Q2 2022 | $30,000 | -60.5% | 40,832 | 0.0% | 0.00% | – |
Q1 2022 | $76,000 | -35.0% | 40,832 | 0.0% | 0.00% | – |
Q4 2021 | $117,000 | -44.0% | 40,832 | 0.0% | 0.00% | – |
Q3 2021 | $209,000 | +5.0% | 40,832 | 0.0% | 0.00% | – |
Q2 2021 | $199,000 | -68.7% | 40,832 | -67.2% | 0.00% | – |
Q1 2021 | $635,000 | -3.3% | 124,592 | -6.7% | 0.00% | – |
Q4 2020 | $657,000 | -78.7% | 133,527 | +4.2% | 0.00% | – |
Q3 2020 | $3,082,000 | -35.4% | 128,112 | +4.2% | 0.00% | – |
Q2 2020 | $4,768,000 | +23.3% | 122,939 | +10.5% | 0.00% | – |
Q1 2020 | $3,868,000 | -1.0% | 111,273 | +30.7% | 0.00% | – |
Q4 2019 | $3,906,000 | – | 85,110 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |